SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023)

SS Innovations International's (SSII) quarterly Income from Non-Controlling Interests came in at $696291.0 in Q3 2023, up 188.13% year-on-year from $241661.5 in Q3 2022, and up 120.41% quarter-over-quarter from -$3.4 million in Q2 2023.

SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

SS Innovations International has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting $696291.0 for Q3 2023.

  • Income from Non-Controlling Interests for Q3 2023 came in at $696291.0, up 188.13% year-over-year; the trailing twelve-month figure through Sep 2023 was -$4.1 million (changed N/A YoY), and the FY2021 annual result was $352.0, changed N/A from the prior year.
  • Income from Non-Controlling Interests came in at $696291.0 for Q3 2023 at SS Innovations International, up from -$3.4 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $696291.0 in Q3 2023 to a low of -$3.4 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 6.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 22.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -5.85 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 100,000.00
10 SS Innovations International 656.63 Mn 633.02 Mn 5.33 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 696,291.00
Jun 30, 2023 -3.41 Mn
Sep 30, 2022 -790,103.00
Jun 30, 2022 -582,023.00